Citigroup Inc Si Bone, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Si Bone, Inc. stock. As of the latest transaction made, Citigroup Inc holds 29,916 shares of SIBN stock, worth $363,479. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,916

Previous 9,102 228.68%

Holding current value

$363,479

Previous $117,000 257.26%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$12.9 - $17.11 $268,500 - $356,127	20,814 Added 228.68%	29,916 $418,000
Q2 2024 Aug 12, 2024	BUY	$11.93 - $16.34 $23,967 - $32,827	2,009 Added 28.32%	9,102 $117,000
Q1 2024 May 10, 2024	BUY	$15.15 - $21.58 $22,331 - $31,808	1,474 Added 26.23%	7,093 $116,000
Q4 2023 Feb 09, 2024	BUY	$15.75 - $21.38 $86,373 - $117,247	5,484 Added 4062.22%	5,619 $117,000
Q3 2023 Nov 09, 2023	SELL	$20.22 - $27.36 $225,493 - $305,118	-11,152 Reduced 98.8%	135 $2,000
Q2 2023 Aug 10, 2023	BUY	$19.39 - $28.9 $203,517 - $303,334	10,496 Added 1326.93%	11,287 $304,000
Q1 2023 May 11, 2023	SELL	$12.71 - $21.17 $2,097 - $3,493	-165 Reduced 17.26%	791 $15,000
Q4 2022 Feb 09, 2023	SELL	$11.23 - $19.44 $3,032 - $5,248	-270 Reduced 22.02%	956 $13,000
Q3 2022 Nov 10, 2022	SELL	$12.2 - $18.71 $20,008 - $30,684	-1,640 Reduced 57.22%	1,226 $21,000
Q2 2022 Aug 10, 2022	BUY	$12.05 - $22.74 $9,808 - $18,510	814 Added 39.67%	2,866 $38,000
Q1 2022 May 12, 2022	SELL	$18.32 - $23.03 $121,644 - $152,919	-6,640 Reduced 76.39%	2,052 $47,000
Q4 2021 Feb 10, 2022	BUY	$18.75 - $24.8 $59,568 - $78,789	3,177 Added 57.61%	8,692 $193,000
Q3 2021 Nov 10, 2021	BUY	$19.65 - $31.89 $108,369 - $175,873	5,515 New	5,515 $118,000

Others Institutions Holding SIBN

# of Institutions

139

Shares Held

41.4M

Call Options Held

266K

Put Options Held

252K

View Full List

About SI-BONE, Inc.

Ticker SIBN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 34,305,000
Market Cap $417M
Description
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...

More about SIBN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account